# Effects of Combination Therapy With Alpha-1 Blocker (Bunazosin or Doxazosin) in the Treatment of Patients With Mild to Moderate Essential Hypertension

> **NCT00130156** · PHASE4 · COMPLETED · sponsor: **Eisai Inc.** · enrollment: 93 (actual)

## Conditions studied

- High Blood Pressure

## Interventions

- **DRUG:** Bunazosin
- **DRUG:** Doxazosin
- **DRUG:** Valsartin

## Key facts

- **NCT ID:** NCT00130156
- **Lead sponsor:** Eisai Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2005-10
- **Primary completion:** 2008-09
- **Final completion:** 2009-03
- **Target enrollment:** 93 (ACTUAL)
- **Last updated:** 2013-05-14

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00130156

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00130156, "Effects of Combination Therapy With Alpha-1 Blocker (Bunazosin or Doxazosin) in the Treatment of Patients With Mild to Moderate Essential Hypertension". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT00130156. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*